Artiva Biotherapeutics (ARTV) Prepaid Assets (2023 - 2026)

Artiva Biotherapeutics (ARTV) has reported Prepaid Assets for 4 consecutive years, with $2.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Prepaid Assets fell 48.57% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $2.0 million (down 48.57% YoY), while the FY2025 annual figure was $4.6 million, up 50.18% from the prior year.
• Prepaid Assets eased to $2.0 million in Q1 2026 per ARTV's latest filing, from $4.6 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $6.7 million in Q2 2025 and bottomed at $1.1 million in Q4 2023.
• Historically, Prepaid Assets has averaged $3.6 million across 4 years, with a median of $3.2 million in 2024.
• Annual changes were most pronounced in 2025 — Prepaid Assets jumped 285.16% — and 2026, when it tumbled 48.57%.
• Artiva Biotherapeutics' Prepaid Assets stood at $1.1 million in 2023, then soared by 179.95% to $3.1 million in 2024, then jumped by 50.18% to $4.6 million in 2025, then tumbled by 57.35% to $2.0 million in 2026.
• Business Quant data shows ARTV's Prepaid Assets at $2.0 million in Q1 2026, $4.6 million in Q4 2025, and $6.5 million in Q3 2025.